Navigation Links
NASA selects DNA Medicine Institute's Nanoscale Diagnostics Technology for Phase II SBIR

CAMBRIDGE, Mass., Jan. 28 /PRNewswire/ -- DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced it has been awarded a Phase II Small Business Innovation Research (SBIR) contract from the National Aeronautics and Space Administration (NASA).  The contract is designed to develop nanoscale diagnostic technologies that facilitate whole health analysis in a single drop of blood.  The Institute will develop assays for assessment of bone loss, immune function, cardiac health, liver function, and lipid status.  The nanoscale diagnostic platform is designed to make hospital tests, currently performed on large machines with trained personnel, possible under any scenario.  This includes confined space flight environments and other field settings where medical information is vital, but inaccessible.  The Institute envisions that this technology will be used in conjunction with its Universal Blood Sensor platform designed to shrink a hospital testing lab onto a handheld, point-of-care device.

"We are pleased to work with NASA in developing technologies for monitoring crew health during space flight, including journeys to the space station and other manned space missions," said Eugene Y. Chan, M.D., President and Chief Scientific Officer of the DNA Medicine Institute.  "This funding will allow us to develop innovations for diagnosing medical conditions in unique environments with minimal amounts of blood and reagents."

The DNA Medicine Institute was awarded a Phase I NASA SBIR grant in 2008.  During this Phase I project, the Institute met key milestones for developing novel nanoscale diagnostic technologies.

About DNA Medicine Institute

The DNA Medicine Institute is a commercial organization whose mission is to advance patient care, alleviate human suffering, and treat disease through innovation.  Founded by Eugene Y. Chan, M.D., its core beliefs are that successful, innovative commercial products can make a long-lasting impact on patient care.  It currently does research on intuitive medical devices, smartly designed drugs, and powerful research instrumentation.  One of these is the Universal Blood Sensor, a technology designed to perform a full health analysis of a person, anywhere, anytime, and with a single drop of blood.  The DNA Medicine Institute's multi-faceted approach to innovation draws upon diverse fields including medicine, nanotechnology, genomics, biophysics, biochemistry, molecular biology, and advanced engineering.  For more information, visit:

SOURCE DNA Medicine Institute

SOURCE DNA Medicine Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Central Garden & Pet Selects SiteHawk as Its MSDS Management Provider
2. NewYork-Presbyterian Hospital Selects Omnicell for Medication Management
3. Virtua Selects Nuvon, Inc. as its Device Connectivity and Integration Solution Provider
4. Legacy Health Selects Allscripts Care Management for Hospitals and Post-Acute Care Facilities
5. Catholic Health Initiatives Selects Allscripts Electronic Health Record for Over 1000 Physicians in 19 States
6. Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management
7. New Mexico VA Health Care System Selects Sensotech Wireless Temperature Monitoring System
8. bioMerieux Selects Brainware to Automate Accounts Payable
9. Blue Cross Blue Shield of Michigan Selects Kevin Klobucar to Lead Blue Care Network as President
10. Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications
11. Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Since its ... comprehensive solutions involving adult stem cell therapies to patients with chronic degenerative medical ... name as a Registered Trademark (RTM). , Organizations are required to hold a ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Todd S. Afferica, a noted ... to many of his patients. Dr. Afferica now uses the BIOLASE WaterLase iPlus 2.0™ ... of time the doctor uses other traditional cutting tools, such as the scalpel and ...
(Date:11/24/2015)... ... , ... In an article published November 12th by Obesity News ... or are not eligible for bariatric surgery. The article explains that candidates for weight ... 100 pounds overweight, or have a BMI of 35 and over with at least ...
(Date:11/24/2015)... Salt Lake City, UT (PRWEB) , ... November 24, 2015 , ... ... according to Forbes Magazine. For a business, it is critical that the first impression ... of a business, they are not likely to buy anything or want to return. ...
(Date:11/24/2015)... ... 2015 , ... Cancer patients, survivors, caregivers, family members and ... taping of the next CURE Connections® video series on Saturday, Dec. ... at Georgetown University Hotel & Conference Center in Washington, D.C. , CURE Connections, ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 24, 2015 ... --> adds Latest Guidebook for ... of 217 pages published in November 2015 to ... online business intelligence library at . ... of the fastest growing global economies with a ...
(Date:11/24/2015)... LONDON , November 24, 2015 ... platform for scientists - since it was launched just six ... collaboration, reference management and authoring platform for scientists - since ... One million references have been loaded on to F1000Workspace ... for scientists - since it was launched just six months ...
(Date:11/24/2015)... , November 24, 2015 st  Scientific ... North America (RSNA) taking place in Chicago ... Booth 1122, Hall A. --> st  Scientific Assembly and ... (RSNA) taking place in Chicago ... Hall A. --> Molecular Dynamics will present its revolutionary ...
Breaking Medicine Technology: